Literature DB >> 17392702

Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome.

Jose M Belloso1, Iben Bache, Miriam Guitart, Maria Rosa Caballin, Christina Halgren, Maria Kirchhoff, Hans-Hilger Ropers, Niels Tommerup, Zeynep Tümer.   

Abstract

Caspr2 is a member of neurexin superfamily, members of which are transmembrane proteins that mediate cellular interactions in the nervous system. Recently, truncation of the CNTNAP2 gene coding for the Caspr2 protein has been suggested to be associated with the Gilles de la Tourette syndrome, a neurological disorder characterized by motor and vocal tics, and behavioral anomalies. In this study, we describe a familial balanced reciprocal translocation t(7;15)(q35;q26.1) in phenotypically normal individuals. The 7q35 breakpoint disrupts the CNTNAP2 gene, indicating that truncation of this gene does not necessarily lead to the symptoms of the complex Gilles de la Tourette syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392702     DOI: 10.1038/sj.ejhg.5201824

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  36 in total

Review 1.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

2.  Severe Intellectual Disability Associated with Recessive Defects in CNTNAP2 and NRXN1.

Authors:  C Zweier
Journal:  Mol Syndromol       Date:  2011-09-08

Review 3.  Tourette syndrome: gene expression as a tool to discover drug targets.

Authors:  Isaac H Liao; Frank R Sharp
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

4.  Chromosomal rearrangements in Tourette syndrome: implications for identification of candidate susceptibility genes and review of the literature.

Authors:  Birgitte Bertelsen; Nanette Mol Debes; Lena E Hjermind; Liselotte Skov; Karen Brøndum-Nielsen; Zeynep Tümer
Journal:  Neurogenetics       Date:  2013-08-29       Impact factor: 2.660

5.  Inherited genetic variants in autism-related CNTNAP2 show perturbed trafficking and ATF6 activation.

Authors:  Giulia Falivelli; Antonella De Jaco; Flores Lietta Favaloro; Hyuck Kim; Jennifer Wilson; Noga Dubi; Mark H Ellisman; Brett S Abrahams; Palmer Taylor; Davide Comoletti
Journal:  Hum Mol Genet       Date:  2012-08-07       Impact factor: 6.150

Review 6.  Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-02-03

Review 7.  Genetic advances in the study of speech and language disorders.

Authors:  D F Newbury; A P Monaco
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

Review 8.  Shining a light on CNTNAP2: complex functions to complex disorders.

Authors:  Pedro Rodenas-Cuadrado; Joses Ho; Sonja C Vernes
Journal:  Eur J Hum Genet       Date:  2013-05-29       Impact factor: 4.246

9.  Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development.

Authors:  Garret R Anderson; Timothy Galfin; Wei Xu; Jason Aoto; Robert C Malenka; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-16       Impact factor: 11.205

10.  Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35).

Authors:  Kerry K Brown; Jacob A Reiss; Kate Crow; Heather L Ferguson; Chantal Kelly; Bernd Fritzsch; Cynthia C Morton
Journal:  Hum Genet       Date:  2010-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.